Panagiotoglou Dimitra, Peterson Sandra, Lavergne M Ruth, Gomes Tara, Chadha Rashmi, Johnson Cheyenne, McCracken Rita
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.
Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC, Canada.
Harm Reduct J. 2025 Jun 25;22(1):111. doi: 10.1186/s12954-025-01261-5.
Opioid agonist treatment (OAT) is the gold standard of care for patients living with opioid use disorder. Since 2016, efforts to expand OAT access have focused on primary care physicians. This study aimed to understand how OAT-prescribing-naïve primary care physicians who began prescribing OAT differed from their peers who did not.
We used administrative health data to identify all patients eligible for OAT initiation between 1 January 2016 and 31 December 2019. We matched primary care visits that resulted in an OAT dispensation with visits that did not. We conducted logistic regression with generalized estimating equations to identify physician demographics and practice characteristics associated with becoming an OAT prescriber.
Of the 4253 primary care physicians who were OAT-prescribing-naïve before 2016, 2183 (51.3%) began prescribing OAT. Physicians who practiced in rural settings (aOR = 1.78, 95% CI: 1.32, 2.40) or saw fewer than 16 patients a day (aOR = 1.46, 95% CI: 1.21, 1.75) were more likely to become OAT prescribers. The likelihood of becoming an OAT prescriber declined with the proportion of visits delivered out of office (aOR = 0.20, 95% CI: 0.16, 0.26) and years since graduation (e.g., physicians who graduated between 2000-2009 were 20% less likely to initiate (aOR = 0.80, 95% CI: 0.64, 0.99) compared with peers who graduated since 2010).
Physicians who saw fewer patients and worked across fewer settings were more likely to become OAT prescribers. However, physicians in rural settings are stepping in to address unmet demand despite resource and time constraints. Understanding the differences between physicians who become OAT prescribers and peers who do not is critical to effectively target interventions to improve OAT access in the future.
阿片类激动剂治疗(OAT)是阿片类物质使用障碍患者护理的金标准。自2016年以来,扩大OAT可及性的努力主要集中在初级保健医生身上。本研究旨在了解开始开具OAT处方的初级保健医生与未开具处方的同行有何不同。
我们利用行政卫生数据确定了2016年1月1日至2019年12月31日期间所有符合开始接受OAT治疗条件的患者。我们将导致开具OAT处方的初级保健就诊与未开具处方的就诊进行匹配。我们使用广义估计方程进行逻辑回归,以确定与成为OAT处方医生相关的医生人口统计学和执业特征。
在2016年前未开具OAT处方的4253名初级保健医生中,2183名(51.3%)开始开具OAT处方。在农村地区执业的医生(调整后比值比[aOR]=1.78,95%置信区间[CI]:1.32,2.40)或每天看诊患者少于16名的医生(aOR=1.46,95%CI:1.21,1.75)更有可能成为OAT处方医生。成为OAT处方医生的可能性随着非门诊就诊比例(aOR=0.20,95%CI:0.16,0.26)和毕业年限的增加而降低(例如,2000年至2009年毕业的医生与2010年以后毕业的同行相比,开始开具处方的可能性降低20%[aOR=0.80,95%CI:0.64,0.99])。
看诊患者较少且工作环境较少的医生更有可能成为OAT处方医生。然而,尽管存在资源和时间限制,农村地区的医生仍在介入以满足未满足的需求。了解成为OAT处方医生的医生与未成为处方医生的同行之间的差异,对于有效开展干预措施以改善未来OAT的可及性至关重要。